The Current Ratio as of December 2025 (TTM) for Brainstorm Cell Therapeutics Inc. (BCLI) is 0.06

According to Brainstorm Cell Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.06. This represents a change of -54.11% compared to the average of 0.12 of the last 4 quarters.

Brainstorm Cell Therapeutics Inc. (BCLI) Historical Current Ratio (quarterly & annually)

How has BCLI Current Ratio performed in the past?

The mean historical Current Ratio of Brainstorm Cell Therapeutics Inc. over the last ten years is 2.95. The current 0.06 Current Ratio has changed 90.66% with respect to the historical average. Over the past ten years (40 quarters), BCLI's Current Ratio was at its highest in in the December 2016 quarter at 12.09. The Current Ratio was at its lowest in in the December 2024 quarter at 0.04.

Brainstorm Cell Therapeutics Inc. (BCLI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Brainstorm Cell Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Brainstorm Cell Therapeutics Inc. (BCLI) Average Current Ratio

How has BCLI Current Ratio performed in the past?

The current Current Ratio of Brainstorm Cell Therapeutics Inc. (BCLI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Brainstorm Cell Therapeutics Inc. (BCLI) Current Ratio vs. Peers

How is BCLI’s Current Ratio compared to its peers?

Brainstorm Cell Therapeutics Inc.’s Current Ratio is less than NeuroSense Therapeutics Ltd. (0.71), less than Matinas BioPharma Holdings, Inc. (3.78), less than Adial Pharmaceuticals, Inc. (4.34), less than Cardio Diagnostics Holdings, Inc. (23.55), less than HCW Biologics Inc. (0.06), less than Impact BioMedical Inc. (0.06), less than Acurx Pharmaceuticals, Inc. (2.39), less than VYNE Therapeutics Inc. (8.87), less than Addex Therapeutics Ltd (2.31), less than BioCardia, Inc. (1.62),

Build a custom stock screener for Brainstorm Cell Therapeutics Inc. (BCLI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Brainstorm Cell Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Brainstorm Cell Therapeutics Inc. (BCLI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Brainstorm Cell Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.